Experts urge caution over drug company campaigns to destigmatize obesity
We should be wary of campaigns by pharmaceutical companies to destigmatize obesity, say experts in The BMJ. Michael Viggars and colleagues argue that, while destigmatizing obesity is the right thing to do, there is a risk that companies profiting from obesity treatment come to influence public conversation and national policy.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Christchurch mutation points to potential gene therapy avenue for Parkinson's
United Kingdom
-
The way food feels in your mouth could change how much you eat
United Kingdom
-
Infrared beams could illuminate a path toward stronger brain–body connections
United Kingdom
-
Exercise benefits people with chronic disease, but does the type matter?
United Kingdom
-
'Living medicine' tackles drug-resistant biofilms growing on ventilation tubes
United Kingdom
-
Public awareness and tighter prescribing restrictions linked to decline in pregabalin misuse
United Kingdom
-
Pausing blood pressure meds on day of surgery benefits older adults
United Kingdom
-
Ballet dancers show distinct brain responses to other people's facial emotions
United Kingdom